The TB Alliance and its partners will be presenting recent advances in TB research and development at the ICAAC 2011 conference. Posters and presentations will detail results from the first-ever clinical trial of a novel TB regimen, pre-clinical research identifying promising future regimens, and progress on the development of an exciting new class of anti-TB compounds.
A full schedule of TB Alliance presentations is below. Biographies and pictures of presenters can be viewed by clicking on their names.
4th Int'l Workshop on Clinical Pharmacology of TB Drugs
| Combination therapy with novel TB drugs |
| 16th September 2011 |
| 11:30 AM -12:00 PM |
| Workshop presentation |
| Khisi Mduli |
| Hotel Congress Plaza |
| Novel TMC207-containing regimens have sterilizing activity in murine tuberculosis |
| 16th September 2011 |
| Workshop presentation |
| Eric Nuermberger |
| Hotel Congress Plaza |
| EBA, Theoretical aspects and practical experience |
| 16th September 2011 |
| 4:15 – 4:30 PM |
| Workshop presentation |
| Andreas Diacon |
| Hotel Congress Plaza |
ICAAC 2011
| SAR of Riminophenazine Class and Discovery of New Anti-tuberculosis Agents Active against Multidrug-Resistant Tuberculosis |
| 17th September 2011 |
| 12:30 - 1:30 PM |
| Topical Poster Walk presentation |
| Chris Cooper |
| Exhibit Hall F1 |
| Development of riminophenazines for the treatment of tuberculosis |
| 17th September 2011 |
| 1:45 - 3:45 PM |
| Poster Summary Session on novel antimicrobial agents and strategies |
| Anna Upton |
| Room W375c |
| Pyrazinamide Increases the Early Bactericidal Activity of TMC207 and PA-824 in Patients with Newly Diagnosed, Smear-positive Pulmonary Tuberculosis |
| 18th September 2011 |
| 11:15 AM |
| Poster (P-931a) |
| Andreas Diacon |
| Exhibit Hall F1 |
| Phase 2 Trial of a Novel 3-Drug Regimen for Both MDR and Drug Sensitive (DS) TB |
| 18th September 2011 |
| 11:15 AM |
| Poster (P-931b) |
| Andreas Diacon |
| Exhibit Hall F1 |
| SAR of Riminophenazine Class and Discovery of New Anti-tuberculosis Agents Active against Multidrug-Resistant Tuberculosis |
| 19th September 2011P.M. |
| 11:15 AM -1:15 PM |
| Poster (F1-1358) |
| Chris Cooper |
| Exhibit Hall F1 |
| Clofazimine Analogs with Superior Efficacy against Experimental Tuberculosis and Reduced Potential for Tissue Discoloration |
| 19th September 2011 |
| 11:15 AM -1:15 PM |
| Poster (F1-1359) |
| Zhenkun Ma |
| Exhibit Hall F1 |
| Anti-tubercular Clofazimine Analogs that Demonstrate a Range of Tissue Distribution Patterns Following Eight Weeks of Dosing to mice |
| 19th September 2011 |
| 11:15 AM - 1:15 PM |
| Poster (F1-1360) |
| Anna Upton |
| Exhibit Hall F1 |
| Novel TMC207-containing Regimens Have Sterilizing Activity In Murine Tuberculosis |
| 19th September 2011 |
| 11:15 AM |
| Poster (B-1205) |
| Eric Nuermberger |
| Exhibit Hall F1 |